165 related articles for article (PubMed ID: 18442089)
1. HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion.
Golembieski WA; Thomas SL; Schultz CR; Yunker CK; McClung HM; Lemke N; Cazacu S; Barker T; Sage EH; Brodie C; Rempel SA
Glia; 2008 Aug; 56(10):1061-75. PubMed ID: 18442089
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the SPARC acidic domain or EGF-like module reduces SPARC-induced migration and signaling through p38 MAPK/HSP27 in glioma.
McClung HM; Golembieski WA; Schultz CR; Jankowski M; Schultz LR; Rempel SA
Carcinogenesis; 2012 Feb; 33(2):275-84. PubMed ID: 22114076
[TBL] [Abstract][Full Text] [Related]
3. PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.
Alam R; Schultz CR; Golembieski WA; Poisson LM; Rempel SA
Neuro Oncol; 2013 Apr; 15(4):451-61. PubMed ID: 23382286
[TBL] [Abstract][Full Text] [Related]
4. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.
Schultz CR; Golembieski WA; King DA; Brown SL; Brodie C; Rempel SA
Mol Cancer; 2012 Apr; 11():20. PubMed ID: 22480225
[TBL] [Abstract][Full Text] [Related]
7. cDNA array analysis of SPARC-modulated changes in glioma gene expression.
Golembieski WA; Rempel SA
J Neurooncol; 2002 Dec; 60(3):213-26. PubMed ID: 12510773
[TBL] [Abstract][Full Text] [Related]
8. A study of SPARC and vitronectin localization and expression in pediatric and adult gliomas: high SPARC secretion correlates with decreased migration on vitronectin.
Menon PM; Gutierrez JA; Rempel SA
Int J Oncol; 2000 Oct; 17(4):683-93. PubMed ID: 10995878
[TBL] [Abstract][Full Text] [Related]
9. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo.
Schultz C; Lemke N; Ge S; Golembieski WA; Rempel SA
Cancer Res; 2002 Nov; 62(21):6270-7. PubMed ID: 12414657
[TBL] [Abstract][Full Text] [Related]
10. Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases.
Shi Q; Bao S; Song L; Wu Q; Bigner DD; Hjelmeland AB; Rich JN
Oncogene; 2007 Jun; 26(28):4084-94. PubMed ID: 17213807
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells.
Sosa MS; Girotti MR; Salvatierra E; Prada F; de Olmo JA; Gallango SJ; Albar JP; Podhajcer OL; Llera AS
Proteomics; 2007 Nov; 7(22):4123-34. PubMed ID: 17994631
[TBL] [Abstract][Full Text] [Related]
12. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling.
Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA
Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716
[TBL] [Abstract][Full Text] [Related]
13. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
[TBL] [Abstract][Full Text] [Related]
14. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated coexpression of DCX and SPARC radiosensitizes human malignant glioma cells.
Xu Y; Yang L; Jiang X; Yu J; Yang J; Zhang H; Tai G; Yuan X; Liu F
Cell Mol Neurobiol; 2013 Oct; 33(7):965-71. PubMed ID: 23846421
[TBL] [Abstract][Full Text] [Related]
16. Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA.
Dejeans N; Pluquet O; Lhomond S; Grise F; Bouchecareilh M; Juin A; Meynard-Cadars M; Bidaud-Meynard A; Gentil C; Moreau V; Saltel F; Chevet E
J Cell Sci; 2012 Sep; 125(Pt 18):4278-87. PubMed ID: 22718352
[TBL] [Abstract][Full Text] [Related]
17. SPARC mediates Src-induced disruption of actin cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42.
Bhoopathi P; Gondi CS; Gujrati M; Dinh DH; Lakka SS
Cell Signal; 2011 Dec; 23(12):1978-87. PubMed ID: 21798346
[TBL] [Abstract][Full Text] [Related]
18. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
Xu L; Chen S; Bergan RC
Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
[TBL] [Abstract][Full Text] [Related]
19. SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.
Yunker CK; Golembieski W; Lemke N; Schultz CR; Cazacu S; Brodie C; Rempel SA
Int J Cancer; 2008 Jun; 122(12):2735-43. PubMed ID: 18350569
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Yoshimura T; Nagahara M; Kuo C; Turner RR; Soon-Shiong P; Hoon DS
Epigenetics; 2011 Aug; 6(8):1001-11. PubMed ID: 21725199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
